期刊文献+

CD44和RHAMM在胃肠肿瘤中的表达及其临床意义

Detection of CD44 and RHAMM Expression and Prognosis in Gastrointestinal Tumors by Real-time Fluorescence Quantitative PCR
下载PDF
导出
摘要 目的研究实时荧光定量PCR检测CD44和RHAMM在胃肠肿瘤中的表达及其临床意义。方法随机选取胃肠肿瘤患者95例,将肿瘤组织及其周边5cm以上的正常组织取出来,保存在液氮中。进行总RNA抽提与cDNA合成、逆转录-PCR、CD44、RHAMM GAPDH质粒制备、实时PCR。结果实时荧光定量PCR检测CD44、RHAMM在胃肠肿瘤组织中的表达均显著高于正常组织(P<0.05)。CD44和RHAMM在胃肠肿瘤的表达显著相关(P<0.05),其中肠道、有淋巴结转移CD44和RHAMM均呈显著的正相关关系(P<0.05),但胃部、无淋巴结转移CD44和RHAMM均无相关性(P>0.05)。结论实时荧光定量PCR检测CD44和RHAMM在胃肠肿瘤组织中的表达均高于正常组织,且具有相关性,能够对肿瘤淋巴结转移情况进行判定参考。 Objective To study the expression and prognosis of CD44 and RHAMM in gastrointestinal tumors by real-time fluorescence quantitative PCR.Methods 95 patients with gastrointestinal tumors were randomly selected.The normal tissues above 5 cm around the tumors were taken out and stored in liquid nitrogen.Total RNA extraction and DNA synthesis,reverse transcription-PCR,CD44,RHAMM GAPDH plasmid preparation,real-time PCR were carried out.Results The expression of CD44 in gastrointestinal tumors was significantly higher than that in normal tissues by real-time fluorescence quantitative PCR(P<0.05).The expression of RHAMM in gastrointestinal tumors was significantly higher than that in normal tissues by real-time fluorescence quantitative PCR(P<0.05).CD44 and RHAMM were positively correlated in intestinal tract,lymph node metastasis(P<0.05),but not in stomach and non-lymph node metastasis(P>0.05).Conclusion The expression of CD44 and RHAMM in gastrointestinal cancer tissues detected by real-time fluorescence quantitative PCR is higher than that in normal tissues,and has correlation.It can provide effective basis for clinical diagnosis of lymph node metastasis.
作者 王建芳 康乐 宋红杰 WANG Jianfang;KANG Le;SONG Hongjie(Zhumadian Central Hospital,Zhumadian,463000)
出处 《实用癌症杂志》 2020年第4期530-533,共4页 The Practical Journal of Cancer
基金 2018年度河南省医学科技攻关项目(编号:2018020504)。
关键词 实时荧光定量PCR CD44 RHAMM 胃肠肿瘤 表达 预后 Real-time fluorescence quantitative PCR CD44 RHAMM Gastrointestinal neoplasms Expression Prognosis
  • 相关文献

参考文献10

二级参考文献58

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin, 2007, 57 (1): 43-66.
  • 2Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet, 2000, 26 (1): 16-17.
  • 3Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell, 1996, 87 (2): 159-170.
  • 4Deng G, Song GA, Pong E, et al. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor. Cancer Res, 2004, 64 (8): 2692-2698.
  • 5Deng G, Chen A, Hong J, et al. Methylation of CpG in a small region of the hMLHI promoter invariably correlates with the absence of gene expression. Cancer Res, 1999, 59 (9): 2029-2033.
  • 6Noda H, Kato Y, Yoshikawa H, et al. Microsatellite instability caused by hMLH1 promoter methylation increases with tumor progression in right-sided sporadic coloreetal cancer. Oncology, 2005, 69 (4): 354-362.
  • 7Yu J, Mallon MA, Zhang W, et al. DNA repair pathway profiling and mierosatellite instability in eoloreetal cancer. Clin Caneer Res, 2006, 12 (17): 5104-5111.
  • 8Toyooka KO, Toyooka S, Maitra A, et al. Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. Am J Pathol, 2002, 161 (2): 629-634.
  • 9Herman JG, Graft JR, Mytihanen S, et al. Methylation- specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996, 93 (18): 9821-9826.
  • 10Jubb AM, Bell SM, Quirke P. Methylation and colorectal cancer. J Pathol, 2001, 195 (1): 111-134.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部